US 7632659
Use of Shigella invaplex to transport functional proteins and transcriptionally active nucleic acids across mammalian cell membranes in vitro and in vivo
granted A61KA61K2039/53A61K2039/543
Quick answer
US patent 7632659 (Use of Shigella invaplex to transport functional proteins and transcriptionally active nucleic acids across mammalian cell membranes in vitro and in vivo) held by The United States of America as represented by the Secretary of the Army expires Mon Dec 10 2029 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America as represented by the Secretary of the Army
- Grant date
- Tue Dec 15 2009 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 10 2029 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 7
- CPC classes
- A61K, A61K2039/53, A61K2039/543, A61K2039/55516, A61K2039/55544